Global Vaccine (Include COVID-19) Market Research Report 2026(Status and Outlook)
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Vaccine (Include COVID-19) market size was estimated at USD 59960.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaccine (Include COVID-19) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaccine (Include COVID-19) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccine (Include COVID-19) market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine (Include COVID-19) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccine (Include COVID-19), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Vaccine (Include COVID-19) market size was estimated at USD 59960.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaccine (Include COVID-19) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaccine (Include COVID-19) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccine (Include COVID-19) market.
Global Vaccine (Include COVID-19) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- KM Biologics
- Pfizer
- Merck
- Sinovac
- Zhejiang Pukang
- Walvax Biotechnology
- Bharat Biotech
- Serum Institute
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- LG Life Sciences
Market Segmentation (by Type)
- Inactivated Vaccine
- Attenuated Vaccine
- mRNA
- Other
Market Segmentation (by Application)
- Public
- Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Vaccine (Include COVID-19) Market
Overview of the regional outlook of the Vaccine (Include COVID-19) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine (Include COVID-19) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccine (Include COVID-19), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaccine (Include COVID-19)
1.2 Key Market Segments
1.2.1 Vaccine (Include COVID-19) Segment by Type
1.2.2 Vaccine (Include COVID-19) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE (INCLUDE COVID-19) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Vaccine (Include COVID-19) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE (INCLUDE COVID-19) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaccine (Include COVID-19) Product Life Cycle
3.3 Global Vaccine (Include COVID-19) Sales by Manufacturers (2020-2025)
3.4 Global Vaccine (Include COVID-19) Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccine (Include COVID-19) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Vaccine (Include COVID-19) Market Competitive Situation and Trends
3.8.1 Vaccine (Include COVID-19) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaccine (Include COVID-19) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) INDUSTRY CHAIN ANALYSIS
4.1 Vaccine (Include COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE (INCLUDE COVID-19) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaccine (Include COVID-19) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaccine (Include COVID-19) Market
5.7 ESG Ratings of Leading Companies
6 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine (Include COVID-19) Sales Market Share by Type (2020-2025)
6.3 Global Vaccine (Include COVID-19) Market Size by Type (2020-2025)
6.4 Global Vaccine (Include COVID-19) Price by Type (2020-2025)
7 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine (Include COVID-19) Market Sales by Application (2020-2025)
7.3 Global Vaccine (Include COVID-19) Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
8 VACCINE (INCLUDE COVID-19) MARKET SALES BY REGION
8.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.2 Global Vaccine (Include COVID-19) Sales Market Share by Region
8.2 Global Vaccine (Include COVID-19) Market Size by Region
8.2.1 Global Vaccine (Include COVID-19) Market Size by Region
8.2.2 Global Vaccine (Include COVID-19) Market Size by Region
8.3 North America
8.3.1 North America Vaccine (Include COVID-19) Sales by Country
8.3.2 North America Vaccine (Include COVID-19) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccine (Include COVID-19) Sales by Country
8.4.2 Europe Vaccine (Include COVID-19) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccine (Include COVID-19) Sales by Region
8.5.2 Asia Pacific Vaccine (Include COVID-19) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaccine (Include COVID-19) Sales by Country
8.6.2 South America Vaccine (Include COVID-19) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaccine (Include COVID-19) Sales by Region
8.7.2 Middle East and Africa Vaccine (Include COVID-19) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VACCINE (INCLUDE COVID-19) MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine (Include COVID-19) by Region(2020-2025)
9.2 Global Vaccine (Include COVID-19) Revenue Market Share by Region (2020-2025)
9.3 Global Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccine (Include COVID-19) Production
9.4.1 North America Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.4.2 North America Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccine (Include COVID-19) Production
9.5.1 Europe Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.5.2 Europe Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccine (Include COVID-19) Production (2020-2025)
9.6.1 Japan Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.6.2 Japan Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccine (Include COVID-19) Production (2020-2025)
9.7.1 China Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.7.2 China Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Vaccine (Include COVID-19) Product Overview
10.1.3 Sanofi Vaccine (Include COVID-19) Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Vaccine (Include COVID-19) Product Overview
10.2.3 CSL Vaccine (Include COVID-19) Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Vaccine (Include COVID-19) Product Overview
10.3.3 GSK Vaccine (Include COVID-19) Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Vaccine (Include COVID-19) Product Overview
10.4.3 Viatris Vaccine (Include COVID-19) Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Vaccine (Include COVID-19) Product Overview
10.5.3 AstraZeneca Vaccine (Include COVID-19) Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Vaccine (Include COVID-19) Product Overview
10.6.3 Hualan Bio Vaccine (Include COVID-19) Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
10.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.8.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 KM Biologics
10.9.1 KM Biologics Basic Information
10.9.2 KM Biologics Vaccine (Include COVID-19) Product Overview
10.9.3 KM Biologics Vaccine (Include COVID-19) Product Market Performance
10.9.4 KM Biologics Business Overview
10.9.5 KM Biologics Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Vaccine (Include COVID-19) Product Overview
10.10.3 Pfizer Vaccine (Include COVID-19) Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Vaccine (Include COVID-19) Product Overview
10.11.3 Merck Vaccine (Include COVID-19) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Sinovac
10.12.1 Sinovac Basic Information
10.12.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.12.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.12.4 Sinovac Business Overview
10.12.5 Sinovac Recent Developments
10.13 Zhejiang Pukang
10.13.1 Zhejiang Pukang Basic Information
10.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
10.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product Market Performance
10.13.4 Zhejiang Pukang Business Overview
10.13.5 Zhejiang Pukang Recent Developments
10.14 Walvax Biotechnology
10.14.1 Walvax Biotechnology Basic Information
10.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
10.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product Market Performance
10.14.4 Walvax Biotechnology Business Overview
10.14.5 Walvax Biotechnology Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Basic Information
10.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Overview
10.15.3 Bharat Biotech Vaccine (Include COVID-19) Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 Serum Institute
10.16.1 Serum Institute Basic Information
10.16.2 Serum Institute Vaccine (Include COVID-19) Product Overview
10.16.3 Serum Institute Vaccine (Include COVID-19) Product Market Performance
10.16.4 Serum Institute Business Overview
10.16.5 Serum Institute Recent Developments
10.17 Panacea Biotec Ltd
10.17.1 Panacea Biotec Ltd Basic Information
10.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
10.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Market Performance
10.17.4 Panacea Biotec Ltd Business Overview
10.17.5 Panacea Biotec Ltd Recent Developments
10.18 Bio-Med
10.18.1 Bio-Med Basic Information
10.18.2 Bio-Med Vaccine (Include COVID-19) Product Overview
10.18.3 Bio-Med Vaccine (Include COVID-19) Product Market Performance
10.18.4 Bio-Med Business Overview
10.18.5 Bio-Med Recent Developments
10.19 Halfkin Bio-Pharmaceuticals
10.19.1 Halfkin Bio-Pharmaceuticals Basic Information
10.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
10.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Market Performance
10.19.4 Halfkin Bio-Pharmaceuticals Business Overview
10.19.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.20 LG Life Sciences
10.20.1 LG Life Sciences Basic Information
10.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Overview
10.20.3 LG Life Sciences Vaccine (Include COVID-19) Product Market Performance
10.20.4 LG Life Sciences Business Overview
10.20.5 LG Life Sciences Recent Developments
11 VACCINE (INCLUDE COVID-19) MARKET FORECAST BY REGION
11.1 Global Vaccine (Include COVID-19) Market Size Forecast
11.2 Global Vaccine (Include COVID-19) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region
11.2.4 South America Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccine (Include COVID-19) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Vaccine (Include COVID-19) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Vaccine (Include COVID-19) by Type (2026-2035)
12.1.2 Global Vaccine (Include COVID-19) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Vaccine (Include COVID-19) by Type (2026-2035)
12.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2026-2035)
12.2.1 Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application
12.2.2 Global Vaccine (Include COVID-19) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaccine (Include COVID-19)
1.2 Key Market Segments
1.2.1 Vaccine (Include COVID-19) Segment by Type
1.2.2 Vaccine (Include COVID-19) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE (INCLUDE COVID-19) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Vaccine (Include COVID-19) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE (INCLUDE COVID-19) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaccine (Include COVID-19) Product Life Cycle
3.3 Global Vaccine (Include COVID-19) Sales by Manufacturers (2020-2025)
3.4 Global Vaccine (Include COVID-19) Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccine (Include COVID-19) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Vaccine (Include COVID-19) Market Competitive Situation and Trends
3.8.1 Vaccine (Include COVID-19) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaccine (Include COVID-19) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) INDUSTRY CHAIN ANALYSIS
4.1 Vaccine (Include COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE (INCLUDE COVID-19) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaccine (Include COVID-19) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaccine (Include COVID-19) Market
5.7 ESG Ratings of Leading Companies
6 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine (Include COVID-19) Sales Market Share by Type (2020-2025)
6.3 Global Vaccine (Include COVID-19) Market Size by Type (2020-2025)
6.4 Global Vaccine (Include COVID-19) Price by Type (2020-2025)
7 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine (Include COVID-19) Market Sales by Application (2020-2025)
7.3 Global Vaccine (Include COVID-19) Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
8 VACCINE (INCLUDE COVID-19) MARKET SALES BY REGION
8.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.2 Global Vaccine (Include COVID-19) Sales Market Share by Region
8.2 Global Vaccine (Include COVID-19) Market Size by Region
8.2.1 Global Vaccine (Include COVID-19) Market Size by Region
8.2.2 Global Vaccine (Include COVID-19) Market Size by Region
8.3 North America
8.3.1 North America Vaccine (Include COVID-19) Sales by Country
8.3.2 North America Vaccine (Include COVID-19) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccine (Include COVID-19) Sales by Country
8.4.2 Europe Vaccine (Include COVID-19) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccine (Include COVID-19) Sales by Region
8.5.2 Asia Pacific Vaccine (Include COVID-19) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaccine (Include COVID-19) Sales by Country
8.6.2 South America Vaccine (Include COVID-19) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaccine (Include COVID-19) Sales by Region
8.7.2 Middle East and Africa Vaccine (Include COVID-19) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VACCINE (INCLUDE COVID-19) MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine (Include COVID-19) by Region(2020-2025)
9.2 Global Vaccine (Include COVID-19) Revenue Market Share by Region (2020-2025)
9.3 Global Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccine (Include COVID-19) Production
9.4.1 North America Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.4.2 North America Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccine (Include COVID-19) Production
9.5.1 Europe Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.5.2 Europe Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccine (Include COVID-19) Production (2020-2025)
9.6.1 Japan Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.6.2 Japan Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccine (Include COVID-19) Production (2020-2025)
9.7.1 China Vaccine (Include COVID-19) Production Growth Rate (2020-2025)
9.7.2 China Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Vaccine (Include COVID-19) Product Overview
10.1.3 Sanofi Vaccine (Include COVID-19) Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Vaccine (Include COVID-19) Product Overview
10.2.3 CSL Vaccine (Include COVID-19) Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Vaccine (Include COVID-19) Product Overview
10.3.3 GSK Vaccine (Include COVID-19) Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Vaccine (Include COVID-19) Product Overview
10.4.3 Viatris Vaccine (Include COVID-19) Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Vaccine (Include COVID-19) Product Overview
10.5.3 AstraZeneca Vaccine (Include COVID-19) Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Vaccine (Include COVID-19) Product Overview
10.6.3 Hualan Bio Vaccine (Include COVID-19) Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
10.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.8.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 KM Biologics
10.9.1 KM Biologics Basic Information
10.9.2 KM Biologics Vaccine (Include COVID-19) Product Overview
10.9.3 KM Biologics Vaccine (Include COVID-19) Product Market Performance
10.9.4 KM Biologics Business Overview
10.9.5 KM Biologics Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Vaccine (Include COVID-19) Product Overview
10.10.3 Pfizer Vaccine (Include COVID-19) Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Vaccine (Include COVID-19) Product Overview
10.11.3 Merck Vaccine (Include COVID-19) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Sinovac
10.12.1 Sinovac Basic Information
10.12.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.12.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.12.4 Sinovac Business Overview
10.12.5 Sinovac Recent Developments
10.13 Zhejiang Pukang
10.13.1 Zhejiang Pukang Basic Information
10.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
10.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product Market Performance
10.13.4 Zhejiang Pukang Business Overview
10.13.5 Zhejiang Pukang Recent Developments
10.14 Walvax Biotechnology
10.14.1 Walvax Biotechnology Basic Information
10.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
10.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product Market Performance
10.14.4 Walvax Biotechnology Business Overview
10.14.5 Walvax Biotechnology Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Basic Information
10.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Overview
10.15.3 Bharat Biotech Vaccine (Include COVID-19) Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 Serum Institute
10.16.1 Serum Institute Basic Information
10.16.2 Serum Institute Vaccine (Include COVID-19) Product Overview
10.16.3 Serum Institute Vaccine (Include COVID-19) Product Market Performance
10.16.4 Serum Institute Business Overview
10.16.5 Serum Institute Recent Developments
10.17 Panacea Biotec Ltd
10.17.1 Panacea Biotec Ltd Basic Information
10.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
10.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Market Performance
10.17.4 Panacea Biotec Ltd Business Overview
10.17.5 Panacea Biotec Ltd Recent Developments
10.18 Bio-Med
10.18.1 Bio-Med Basic Information
10.18.2 Bio-Med Vaccine (Include COVID-19) Product Overview
10.18.3 Bio-Med Vaccine (Include COVID-19) Product Market Performance
10.18.4 Bio-Med Business Overview
10.18.5 Bio-Med Recent Developments
10.19 Halfkin Bio-Pharmaceuticals
10.19.1 Halfkin Bio-Pharmaceuticals Basic Information
10.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
10.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Market Performance
10.19.4 Halfkin Bio-Pharmaceuticals Business Overview
10.19.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.20 LG Life Sciences
10.20.1 LG Life Sciences Basic Information
10.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Overview
10.20.3 LG Life Sciences Vaccine (Include COVID-19) Product Market Performance
10.20.4 LG Life Sciences Business Overview
10.20.5 LG Life Sciences Recent Developments
11 VACCINE (INCLUDE COVID-19) MARKET FORECAST BY REGION
11.1 Global Vaccine (Include COVID-19) Market Size Forecast
11.2 Global Vaccine (Include COVID-19) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region
11.2.4 South America Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccine (Include COVID-19) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Vaccine (Include COVID-19) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Vaccine (Include COVID-19) by Type (2026-2035)
12.1.2 Global Vaccine (Include COVID-19) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Vaccine (Include COVID-19) by Type (2026-2035)
12.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2026-2035)
12.2.1 Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application
12.2.2 Global Vaccine (Include COVID-19) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 4. Global Vaccine (Include COVID-19) Market Size by Application
Table 5. Vaccine (Include COVID-19) Market Size Comparison by Region (M USD)
Table 6. Global Vaccine (Include COVID-19) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Vaccine (Include COVID-19) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Vaccine (Include COVID-19) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2025)
Table 11. Global Market Vaccine (Include COVID-19) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Vaccine (Include COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine (Include COVID-19) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Vaccine (Include COVID-19) Sales by Type (K MT)
Table 27. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 28. Global Vaccine (Include COVID-19) Sales (K MT) by Type (2020-2025)
Table 29. Global Vaccine (Include COVID-19) Sales Market Share by Type (2020-2025)
Table 30. Global Vaccine (Include COVID-19) Market Size (M USD) by Type (2020-2025)
Table 31. Global Vaccine (Include COVID-19) Market Share by Type (2020-2025)
Table 32. Global Vaccine (Include COVID-19) Price (USD/KG) by Type (2020-2025)
Table 33. Global Vaccine (Include COVID-19) Sales (K MT) by Application
Table 34. Global Vaccine (Include COVID-19) Market Size by Application
Table 35. Global Vaccine (Include COVID-19) Sales by Application (2020-2025) & (K MT)
Table 36. Global Vaccine (Include COVID-19) Sales Market Share by Application (2020-2025)
Table 37. Global Vaccine (Include COVID-19) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Vaccine (Include COVID-19) Market Share by Application (2020-2025)
Table 39. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
Table 40. Global Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 41. Global Vaccine (Include COVID-19) Sales Market Share by Region (2020-2025)
Table 42. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025)
Table 44. North America Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 45. North America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 51. South America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Vaccine (Include COVID-19) Production (K MT) by Region(2020-2025)
Table 55. Global Vaccine (Include COVID-19) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Vaccine (Include COVID-19) Revenue Market Share by Region (2020-2025)
Table 57. Global Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Vaccine (Include COVID-19) Product Overview
Table 64. Sanofi Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Vaccine (Include COVID-19) Product Overview
Table 70. CSL Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Vaccine (Include COVID-19) Product Overview
Table 76. GSK Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Vaccine (Include COVID-19) Product Overview
Table 82. Viatris Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Vaccine (Include COVID-19) Product Overview
Table 87. AstraZeneca Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Vaccine (Include COVID-19) Product Overview
Table 92. Hualan Bio Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. Changchun Institute of Biological Basic Information
Table 96. Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
Table 97. Changchun Institute of Biological Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Changchun Institute of Biological Business Overview
Table 99. Changchun Institute of Biological Recent Developments
Table 100. Sinovac Basic Information
Table 101. Sinovac Vaccine (Include COVID-19) Product Overview
Table 102. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinovac Business Overview
Table 104. Sinovac Recent Developments
Table 105. KM Biologics Basic Information
Table 106. KM Biologics Vaccine (Include COVID-19) Product Overview
Table 107. KM Biologics Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. KM Biologics Business Overview
Table 109. KM Biologics Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Vaccine (Include COVID-19) Product Overview
Table 112. Pfizer Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Vaccine (Include COVID-19) Product Overview
Table 117. Merck Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. Sinovac Basic Information
Table 121. Sinovac Vaccine (Include COVID-19) Product Overview
Table 122. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Sinovac Business Overview
Table 124. Sinovac Recent Developments
Table 125. Zhejiang Pukang Basic Information
Table 126. Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
Table 127. Zhejiang Pukang Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Zhejiang Pukang Business Overview
Table 129. Zhejiang Pukang Recent Developments
Table 130. Walvax Biotechnology Basic Information
Table 131. Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
Table 132. Walvax Biotechnology Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Walvax Biotechnology Business Overview
Table 134. Walvax Biotechnology Recent Developments
Table 135. Bharat Biotech Basic Information
Table 136. Bharat Biotech Vaccine (Include COVID-19) Product Overview
Table 137. Bharat Biotech Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Bharat Biotech Business Overview
Table 139. Bharat Biotech Recent Developments
Table 140. Serum Institute Basic Information
Table 141. Serum Institute Vaccine (Include COVID-19) Product Overview
Table 142. Serum Institute Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Serum Institute Business Overview
Table 144. Serum Institute Recent Developments
Table 145. Panacea Biotec Ltd Basic Information
Table 146. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
Table 147. Panacea Biotec Ltd Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Panacea Biotec Ltd Business Overview
Table 149. Panacea Biotec Ltd Recent Developments
Table 150. Bio-Med Basic Information
Table 151. Bio-Med Vaccine (Include COVID-19) Product Overview
Table 152. Bio-Med Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Bio-Med Business Overview
Table 154. Bio-Med Recent Developments
Table 155. Halfkin Bio-Pharmaceuticals Basic Information
Table 156. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
Table 157. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Halfkin Bio-Pharmaceuticals Business Overview
Table 159. Halfkin Bio-Pharmaceuticals Recent Developments
Table 160. LG Life Sciences Basic Information
Table 161. LG Life Sciences Vaccine (Include COVID-19) Product Overview
Table 162. LG Life Sciences Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. LG Life Sciences Business Overview
Table 164. LG Life Sciences Recent Developments
Table 165. Global Vaccine (Include COVID-19) Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Vaccine (Include COVID-19) Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Vaccine (Include COVID-19) Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Vaccine (Include COVID-19) Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 4. Global Vaccine (Include COVID-19) Market Size by Application
Table 5. Vaccine (Include COVID-19) Market Size Comparison by Region (M USD)
Table 6. Global Vaccine (Include COVID-19) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Vaccine (Include COVID-19) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Vaccine (Include COVID-19) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2025)
Table 11. Global Market Vaccine (Include COVID-19) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Vaccine (Include COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine (Include COVID-19) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Vaccine (Include COVID-19) Sales by Type (K MT)
Table 27. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 28. Global Vaccine (Include COVID-19) Sales (K MT) by Type (2020-2025)
Table 29. Global Vaccine (Include COVID-19) Sales Market Share by Type (2020-2025)
Table 30. Global Vaccine (Include COVID-19) Market Size (M USD) by Type (2020-2025)
Table 31. Global Vaccine (Include COVID-19) Market Share by Type (2020-2025)
Table 32. Global Vaccine (Include COVID-19) Price (USD/KG) by Type (2020-2025)
Table 33. Global Vaccine (Include COVID-19) Sales (K MT) by Application
Table 34. Global Vaccine (Include COVID-19) Market Size by Application
Table 35. Global Vaccine (Include COVID-19) Sales by Application (2020-2025) & (K MT)
Table 36. Global Vaccine (Include COVID-19) Sales Market Share by Application (2020-2025)
Table 37. Global Vaccine (Include COVID-19) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Vaccine (Include COVID-19) Market Share by Application (2020-2025)
Table 39. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
Table 40. Global Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 41. Global Vaccine (Include COVID-19) Sales Market Share by Region (2020-2025)
Table 42. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025)
Table 44. North America Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 45. North America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Vaccine (Include COVID-19) Sales by Country (2020-2025) & (K MT)
Table 51. South America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Vaccine (Include COVID-19) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Vaccine (Include COVID-19) Production (K MT) by Region(2020-2025)
Table 55. Global Vaccine (Include COVID-19) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Vaccine (Include COVID-19) Revenue Market Share by Region (2020-2025)
Table 57. Global Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Vaccine (Include COVID-19) Product Overview
Table 64. Sanofi Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Vaccine (Include COVID-19) Product Overview
Table 70. CSL Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Vaccine (Include COVID-19) Product Overview
Table 76. GSK Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Vaccine (Include COVID-19) Product Overview
Table 82. Viatris Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Vaccine (Include COVID-19) Product Overview
Table 87. AstraZeneca Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Vaccine (Include COVID-19) Product Overview
Table 92. Hualan Bio Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. Changchun Institute of Biological Basic Information
Table 96. Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
Table 97. Changchun Institute of Biological Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Changchun Institute of Biological Business Overview
Table 99. Changchun Institute of Biological Recent Developments
Table 100. Sinovac Basic Information
Table 101. Sinovac Vaccine (Include COVID-19) Product Overview
Table 102. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinovac Business Overview
Table 104. Sinovac Recent Developments
Table 105. KM Biologics Basic Information
Table 106. KM Biologics Vaccine (Include COVID-19) Product Overview
Table 107. KM Biologics Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. KM Biologics Business Overview
Table 109. KM Biologics Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Vaccine (Include COVID-19) Product Overview
Table 112. Pfizer Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Vaccine (Include COVID-19) Product Overview
Table 117. Merck Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. Sinovac Basic Information
Table 121. Sinovac Vaccine (Include COVID-19) Product Overview
Table 122. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Sinovac Business Overview
Table 124. Sinovac Recent Developments
Table 125. Zhejiang Pukang Basic Information
Table 126. Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
Table 127. Zhejiang Pukang Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Zhejiang Pukang Business Overview
Table 129. Zhejiang Pukang Recent Developments
Table 130. Walvax Biotechnology Basic Information
Table 131. Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
Table 132. Walvax Biotechnology Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Walvax Biotechnology Business Overview
Table 134. Walvax Biotechnology Recent Developments
Table 135. Bharat Biotech Basic Information
Table 136. Bharat Biotech Vaccine (Include COVID-19) Product Overview
Table 137. Bharat Biotech Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Bharat Biotech Business Overview
Table 139. Bharat Biotech Recent Developments
Table 140. Serum Institute Basic Information
Table 141. Serum Institute Vaccine (Include COVID-19) Product Overview
Table 142. Serum Institute Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Serum Institute Business Overview
Table 144. Serum Institute Recent Developments
Table 145. Panacea Biotec Ltd Basic Information
Table 146. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
Table 147. Panacea Biotec Ltd Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Panacea Biotec Ltd Business Overview
Table 149. Panacea Biotec Ltd Recent Developments
Table 150. Bio-Med Basic Information
Table 151. Bio-Med Vaccine (Include COVID-19) Product Overview
Table 152. Bio-Med Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Bio-Med Business Overview
Table 154. Bio-Med Recent Developments
Table 155. Halfkin Bio-Pharmaceuticals Basic Information
Table 156. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
Table 157. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Halfkin Bio-Pharmaceuticals Business Overview
Table 159. Halfkin Bio-Pharmaceuticals Recent Developments
Table 160. LG Life Sciences Basic Information
Table 161. LG Life Sciences Vaccine (Include COVID-19) Product Overview
Table 162. LG Life Sciences Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. LG Life Sciences Business Overview
Table 164. LG Life Sciences Recent Developments
Table 165. Global Vaccine (Include COVID-19) Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Vaccine (Include COVID-19) Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Vaccine (Include COVID-19) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Vaccine (Include COVID-19) Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Vaccine (Include COVID-19) Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaccine (Include COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine (Include COVID-19) Market Size (M USD), 2025-2035
Figure 5. Global Vaccine (Include COVID-19) Market Size (M USD) (2020-2035)
Figure 6. Global Vaccine (Include COVID-19) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine (Include COVID-19) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccine (Include COVID-19) Product Life Cycle
Figure 13. Vaccine (Include COVID-19) Sales Share by Manufacturers in 2025
Figure 14. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers in 2025
Figure 15. Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Vaccine (Include COVID-19) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccine (Include COVID-19) Revenue in 2025
Figure 18. Industry Chain Map of Vaccine (Include COVID-19)
Figure 19. Global Vaccine (Include COVID-19) Market PEST Analysis
Figure 20. Global Vaccine (Include COVID-19) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccine (Include COVID-19) Market Share by Type
Figure 27. Sales Market Share of Vaccine (Include COVID-19) by Type (2020-2025)
Figure 28. Sales Market Share of Vaccine (Include COVID-19) by Type in 2025
Figure 29. Market Share of Vaccine (Include COVID-19) by Type (2020-2025)
Figure 30. Market Share of Vaccine (Include COVID-19) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccine (Include COVID-19) Market Share by Application
Figure 33. Global Vaccine (Include COVID-19) Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccine (Include COVID-19) Sales Market Share by Application in 2025
Figure 35. Global Vaccine (Include COVID-19) Market Share by Application (2020-2025)
Figure 36. Global Vaccine (Include COVID-19) Market Share by Application in 2025
Figure 37. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccine (Include COVID-19) Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025)
Figure 40. North America Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 43. North America Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 45. U.S. Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccine (Include COVID-19) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaccine (Include COVID-19) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccine (Include COVID-19) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccine (Include COVID-19) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 53. Europe Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 55. Germany Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaccine (Include COVID-19) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccine (Include COVID-19) Market Size by Region in 2024
Figure 68. China Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 79. South America Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 80. South America Vaccine (Include COVID-19) Market Size and Growth Rate (M USD)
Figure 81. South America Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 82. Brazil Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaccine (Include COVID-19) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccine (Include COVID-19) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccine (Include COVID-19) Market Size by Region in 2024
Figure 92. Saudi Arabia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccine (Include COVID-19) Production Market Share by Region (2020-2025)
Figure 103. North America Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaccine (Include COVID-19) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Vaccine (Include COVID-19) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Vaccine (Include COVID-19) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Vaccine (Include COVID-19) Market Share Forecast by Type (2026-2035)
Figure 111. Global Vaccine (Include COVID-19) Sales Forecast by Application (2026-2035)
Figure 112. Global Vaccine (Include COVID-19) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Vaccine (Include COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine (Include COVID-19) Market Size (M USD), 2025-2035
Figure 5. Global Vaccine (Include COVID-19) Market Size (M USD) (2020-2035)
Figure 6. Global Vaccine (Include COVID-19) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine (Include COVID-19) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccine (Include COVID-19) Product Life Cycle
Figure 13. Vaccine (Include COVID-19) Sales Share by Manufacturers in 2025
Figure 14. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers in 2025
Figure 15. Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Vaccine (Include COVID-19) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccine (Include COVID-19) Revenue in 2025
Figure 18. Industry Chain Map of Vaccine (Include COVID-19)
Figure 19. Global Vaccine (Include COVID-19) Market PEST Analysis
Figure 20. Global Vaccine (Include COVID-19) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccine (Include COVID-19) Market Share by Type
Figure 27. Sales Market Share of Vaccine (Include COVID-19) by Type (2020-2025)
Figure 28. Sales Market Share of Vaccine (Include COVID-19) by Type in 2025
Figure 29. Market Share of Vaccine (Include COVID-19) by Type (2020-2025)
Figure 30. Market Share of Vaccine (Include COVID-19) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccine (Include COVID-19) Market Share by Application
Figure 33. Global Vaccine (Include COVID-19) Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccine (Include COVID-19) Sales Market Share by Application in 2025
Figure 35. Global Vaccine (Include COVID-19) Market Share by Application (2020-2025)
Figure 36. Global Vaccine (Include COVID-19) Market Share by Application in 2025
Figure 37. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccine (Include COVID-19) Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025)
Figure 40. North America Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 43. North America Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 45. U.S. Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccine (Include COVID-19) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaccine (Include COVID-19) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccine (Include COVID-19) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccine (Include COVID-19) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 53. Europe Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 55. Germany Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaccine (Include COVID-19) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccine (Include COVID-19) Market Size by Region in 2024
Figure 68. China Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 79. South America Vaccine (Include COVID-19) Sales Market Share by Country in 2024
Figure 80. South America Vaccine (Include COVID-19) Market Size and Growth Rate (M USD)
Figure 81. South America Vaccine (Include COVID-19) Market Size by Country in 2024
Figure 82. Brazil Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaccine (Include COVID-19) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccine (Include COVID-19) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccine (Include COVID-19) Market Size by Region in 2024
Figure 92. Saudi Arabia Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccine (Include COVID-19) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaccine (Include COVID-19) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccine (Include COVID-19) Production Market Share by Region (2020-2025)
Figure 103. North America Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaccine (Include COVID-19) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaccine (Include COVID-19) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Vaccine (Include COVID-19) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Vaccine (Include COVID-19) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Vaccine (Include COVID-19) Market Share Forecast by Type (2026-2035)
Figure 111. Global Vaccine (Include COVID-19) Sales Forecast by Application (2026-2035)
Figure 112. Global Vaccine (Include COVID-19) Market Share Forecast by Application (2026-2035)
